Skip to content
Disclosery

EXANE DERIVATIVES: CWB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CWB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 CWB shares at 2022-03-31 per its 13F-HR filed 2022-04-22.

the latest 13F is the newest step

  1. period ended2022-03-31
    13F 0 shares
    Change vs previous 13F -1,819 shares

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-12-31
    13F 1,819 shares
    Change vs previous 13F -105 shares

    0.04% of the 13F portfolio, value $150,911.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 1,924 shares
    Change vs previous 13F -224 shares

    0.04% of the 13F portfolio, value $164,221.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 2,148 shares
    Change vs previous 13F 0 shares

    0.04% of the 13F portfolio, value $184,454.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 2,148 shares
    Change vs previous 13F -85 shares

    0.05% of the 13F portfolio, value $179,046.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-12-31
    13F 2,233 shares
    Change vs previous 13F -117 shares

    0.06% of the 13F portfolio, value $184,880.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-09-30
    13F/A 2,350 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $161,896.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).